Finally a promising analgesic signal in a long-awaited new class of drugs: TRPV1 antagonist mavatrep in patients with osteoarthritis (OA)

Publication date: October 2017 Source:Scandinavian Journal of Pain, Volume 17 Author(s): Rolf Karlsten
Source: Scandinavian Journal of Pain - Category: Anesthesiology Source Type: research